144 related articles for article (PubMed ID: 7524752)
1. Persistence of affected T lymphocytes in long-term clinical remission in paroxysmal nocturnal hemoglobinuria.
Nakakuma H; Nagakura S; Kawaguchi T; Iwamoto N; Hidaka M; Horikawa K; Kagimoto T; Tsuruzaki R; Takatsuki K
Blood; 1994 Dec; 84(11):3925-8. PubMed ID: 7524752
[TBL] [Abstract][Full Text] [Related]
2. Paroxysmal nocturnal hemoglobinuria clone in bone marrow of patients with pancytopenia.
Nakakuma H; Nagakura S; Iwamoto N; Kawaguchi T; Hidaka M; Horikawa K; Kagimoto T; Shido T; Takatsuki K
Blood; 1995 Mar; 85(5):1371-6. PubMed ID: 7532041
[TBL] [Abstract][Full Text] [Related]
3. Expression of decay-accelerating factor and CD59 in lymphocyte subsets of healthy individuals and paroxysmal nocturnal hemoglobinuria patients.
Nagakura S; Nakakuma H; Horikawa K; Hidaka M; Kagimoto T; Kawakita M; Tomita M; Takatsuki K
Am J Hematol; 1993 May; 43(1):14-8. PubMed ID: 7686331
[TBL] [Abstract][Full Text] [Related]
4. Markedly high population of affected reticulocytes negative for decay-accelerating factor and CD59 in paroxysmal nocturnal hemoglobinuria.
Iwamoto N; Kawaguchi T; Nagakura S; Hidaka M; Horikawa K; Kagimoto T; Takatsuki K; Nakakuma H
Blood; 1995 Apr; 85(8):2228-32. PubMed ID: 7536494
[TBL] [Abstract][Full Text] [Related]
5. Two distinct patterns of glycosylphosphatidylinositol (GPI) linked protein deficiency in the red cells of patients with paroxysmal nocturnal haemoglobinuria.
Hillmen P; Hows JM; Luzzatto L
Br J Haematol; 1992 Mar; 80(3):399-405. PubMed ID: 1374629
[TBL] [Abstract][Full Text] [Related]
6. Discordant and heterogeneous expression of GPI-anchored membrane proteins on leukemic cells in a patient with paroxysmal nocturnal hemoglobinuria.
Shichishima T; Terasawa T; Hashimoto C; Ohto H; Takahashi M; Shibata A; Maruyama Y
Blood; 1993 Apr; 81(7):1855-62. PubMed ID: 7681703
[TBL] [Abstract][Full Text] [Related]
7. Impaired hematopoiesis in paroxysmal nocturnal hemoglobinuria/aplastic anemia is not associated with a selective proliferative defect in the glycosylphosphatidylinositol-anchored protein-deficient clone.
Maciejewski JP; Sloand EM; Sato T; Anderson S; Young NS
Blood; 1997 Feb; 89(4):1173-81. PubMed ID: 9028939
[TBL] [Abstract][Full Text] [Related]
8. Production and characterization of lymphoblastoid cell lines with the paroxysmal nocturnal hemoglobinuria phenotype.
Hillmen P; Bessler M; Crawford DH; Luzzatto L
Blood; 1993 Jan; 81(1):193-9. PubMed ID: 7678064
[TBL] [Abstract][Full Text] [Related]
9. Flow cytometric analysis of glycosylphosphatidyl-inositol-anchored proteins to assess paroxysmal nocturnal hemoglobinuria clone size.
Piedras J; López-Karpovitch X
Cytometry; 2000 Aug; 42(4):234-8. PubMed ID: 10934342
[TBL] [Abstract][Full Text] [Related]
10. Deficient surface expression of glycosylphosphatidylinositol-anchored proteins in B cell lines established from patients with paroxysmal nocturnal hemoglobinuria.
Ueda E; Nishimura J; Kitani T; Nasu K; Kageyama T; Kim YU; Takeda J; Kinoshita T
Int Immunol; 1992 Nov; 4(11):1263-71. PubMed ID: 1282030
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the expression of glycosylphosphatidylinositol anchored proteins on platelets from patients with paroxysmal nocturnal hemoglobinuria.
Maciejewski JP; Young NS; Yu M; Anderson SM; Sloand EM
Thromb Res; 1996 Sep; 83(6):433-47. PubMed ID: 8885138
[TBL] [Abstract][Full Text] [Related]
12. Preferential expression of human Fc gamma RIIIPMN (CD16) in paroxysmal nocturnal hemoglobinuria. Discordant expression of glycosyl phosphatidylinositol-linked proteins.
Edberg JC; Salmon JE; Whitlow M; Kimberly RP
J Clin Invest; 1991 Jan; 87(1):58-67. PubMed ID: 1702101
[TBL] [Abstract][Full Text] [Related]
13. Heterogenous expression of decay accelerating factor and CD59/membrane attack complex inhibition factor on paroxysmal nocturnal haemoglobinuria (PNH) erythrocytes.
Shichishima T; Terasawa T; Hashimoto C; Ohto H; Uchida T; Maruyama Y
Br J Haematol; 1991 Aug; 78(4):545-50. PubMed ID: 1716957
[TBL] [Abstract][Full Text] [Related]
14. Normal patterns of expression of glycosylphosphatidylinositol-anchored proteins on different subsets of peripheral blood cells: a frame of reference for the diagnosis of paroxysmal nocturnal hemoglobinuria.
Hernández-Campo PM; Almeida J; Sánchez ML; Malvezzi M; Orfao A
Cytometry B Clin Cytom; 2006 Mar; 70(2):71-81. PubMed ID: 16493662
[TBL] [Abstract][Full Text] [Related]
15. Correction of the PNH defect by GPI-anchored protein transfer.
Sloand EM; Maciejewski JP; Dunn D; Moss J; Brewer B; Kirby M; Young NS
Blood; 1998 Dec; 92(11):4439-45. PubMed ID: 9834251
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-2-dependent T-cell lines established from paroxysmal nocturnal hemoglobinuria patients.
Nakakuma H; Nagakura S; Horikawa K; Hidaka M; Kawaguchi T; Iwamoto N; Sanada I; Kagimoto T; Takatsuki K
Blood; 1994 Jul; 84(1):309-14. PubMed ID: 7517213
[TBL] [Abstract][Full Text] [Related]
17. Longer in vivo survival of CD59- and decay-accelerating factor-almost normal positive and partly positive erythrocytes in paroxysmal nocturnal hemoglobinuria as compared with negative erythrocytes: a demonstration by differential centrifugation and flow cytometry.
Fujioka S; Yamada T
Blood; 1992 Apr; 79(7):1842-5. PubMed ID: 1373090
[TBL] [Abstract][Full Text] [Related]
18. Defective and normal haematopoietic stem cells in paroxysmal nocturnal haemoglobinuria.
Terstappen LW; Nguyen M; Huang S; Lazarus HM; Medof ME
Br J Haematol; 1993 Jul; 84(3):504-14. PubMed ID: 7692931
[TBL] [Abstract][Full Text] [Related]
19. Analysis of T cells in paroxysmal nocturnal hemoglobinuria provides direct evidence that thymic T-cell production declines with age.
Richards SJ; Morgan GJ; Hillmen P
Blood; 1999 Oct; 94(8):2790-9. PubMed ID: 10515882
[TBL] [Abstract][Full Text] [Related]
20. The PIG-anchoring defect in NK lymphocytes of PNH patients.
Schubert J; Uciechowski P; Delany P; Tischler HJ; Kolanus W; Schmidt RE
Blood; 1990 Sep; 76(6):1181-7. PubMed ID: 1698101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]